Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.

Cell Death Dis · 2016 · PMC4823922 · PMID 26962685

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

AURKA expression levels showed highly significant increase with melanoma progression from nevi ( n =9) to primary ( n =31) and from primary to metastatic ( n =52) stage ( Figure 2g ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.